Related Experiment Video

Updated: Feb 23, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.7K

Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma

Clare F Malone1, Kimberly Stegmaier1

  • 1Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA; Broad Institute, Cambridge, MA 02142, USA.

Cancer Cell
|September 13, 2017
PubMed

Insights

Researchers identified Glypican-2 (GPC2) as a key therapeutic target in neuroblastoma. This cell surface protein is crucial for neuroblastoma growth, and targeting it with an antibody-drug conjugate shows significant therapeutic promise.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Neuroblastoma is a pediatric cancer with limited targeted therapy options.
  • Identifying specific vulnerabilities in cancer cells is crucial for developing effective treatments.

Purpose of the Study:

  • To identify and validate novel therapeutic targets for neuroblastoma.
  • To evaluate the efficacy of targeting Glypican-2 (GPC2) in neuroblastoma.

Main Methods:

  • Analysis of GPC2 expression in neuroblastoma cell lines and patient samples.
  • Functional studies to assess the role of GPC2 in neuroblastoma cell growth and survival.
  • Development and testing of an antibody-drug conjugate (ADC) targeting GPC2.

Main Results:

  • GPC2 is selectively expressed on the surface of neuroblastoma cells.
  • GPC2 was identified as a critical dependency for neuroblastoma.
  • An anti-GPC2 ADC demonstrated significant therapeutic potential in preclinical models.

Conclusions:

  • GPC2 represents a promising and selective therapeutic target for neuroblastoma.
  • Targeting GPC2 with ADCs offers a viable strategy for neuroblastoma treatment.

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.5K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
87.1K